Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Embecta Corp.
Embecta Corp. News
Embecta Corp. Quantitative Score
About Embecta Corp.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Embecta Corp. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Embecta Corp. Financials
Table Compare
Compare EMBC metrics with: | |||
|---|---|---|---|
Earnings & Growth | EMBC | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | EMBC | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | EMBC | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | EMBC | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Embecta Corp. Income
Embecta Corp. Balance Sheet
Embecta Corp. Cash Flow
Embecta Corp. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Buy |
| Return on Equity | Strong Sell |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Embecta Corp. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.6000 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2025-06-13 | 0.15 | Quarterly |
| 2025-03-14 | 0.15 | Quarterly |
| 2024-12-18 | 0.15 | Quarterly |
| 2024-09-13 | 0.15 | Quarterly |
| 2024-06-14 | 0.15 | Quarterly |
Historical Market Cap
Shares Outstanding
Embecta Corp. Executives
| Name | Role |
|---|---|
| Mr. Devdatt Kurdikar Ph.D. | President, Chief Executive Officer & Director |
| Mr. Jacob P. Elguicze | Senior Vice President & Chief Financial Officer |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain |
| Mr. Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary |
| Ms. Jean M. Casner | Senior Vice President & Chief Human Resources Officer |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Devdatt Kurdikar Ph.D. | President, Chief Executive Officer & Director | Male | 1969 | 2.34M |
| Mr. Jacob P. Elguicze | Senior Vice President & Chief Financial Officer | Male | 1973 | 1.12M |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | Male | 1970 | 1.03M |
| Mr. Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary | Male | 1972 | 993.2K |
| Ms. Jean M. Casner | Senior Vice President & Chief Human Resources Officer | Female | 1958 | 811.22K |
Embecta Corp. Insider Trades
| Date | 23 May |
| Name | Melcher David F |
| Role | Director |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 10000 |
| Date | 4 Apr |
| Name | Elguicze Jacob |
| Role | SVP and CFO |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 4948 |
| Date | 4 Apr |
| Name | Curtis Shaun |
| Role | SVP, Global Manuf./Sup. Chain |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 3249 |
| Date | 4 Apr |
| Name | Mann Jeffrey Z |
| Role | SVP, GC, Head Corp. Dev., Secy |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 5285 |
| Date | 4 Apr |
| Name | Kurdikar Devdatt |
| Role | President and CEO |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 39592 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 23 May | Melcher David F | Director | Acquired | P-Purchase | 10000 |
| 4 Apr | Elguicze Jacob | SVP and CFO | Disposed | F-InKind | 4948 |
| 4 Apr | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Disposed | F-InKind | 3249 |
| 4 Apr | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Disposed | F-InKind | 5285 |
| 4 Apr | Kurdikar Devdatt | President and CEO | Disposed | F-InKind | 39592 |